Evidence map›Paper›PMID 17483100›Full record

ArticleSchizophrenia bulletin2007

Recruitment and treatment practices for help-seeking "prodromal" patients.

Thomas H McGlashan, Jean Addington, Tyrone Cannon, Markus Heinimaa, Patrick McGorry, Mary O'Brien, David Penn, Diana Perkins, Raimo K R Salokangas, Barbara Walsh and 2 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Schizophrenia bulletin, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Community Rehabilitation for Youth with Psychosis Spectrum Disorders.Child and adolescent psychiatric clinics of North America · 2020
    Review
  9. Review
  10. Mistiming of thought and perception predicts delusionality.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Chances and risks of predicting psychosis.European archives of psychiatry and clinical neuroscience · 2012
    Review
  19. Whither the attenuated psychosis syndrome?Schizophrenia bulletin · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Thomas H McGlashanDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. thomas.mcglashan@yale.edu
Jean Addington
Tyrone Cannon
Markus Heinimaa
Patrick McGorry
Mary O'Brien
David Penn
Diana Perkins
Raimo K R Salokangas
Barbara Walsh
Scott W Woods
Alison Yung
Yale University · USUniversity of California, Los Angeles · USUniversity of North Carolina at Chapel Hill · USUniversity of Turku · FIOrygen · AUUniversity of Melbourne · AUUniversity of Toronto · CA

Funding

INTERVENING AT PRODROMAL STAGES OF PSYCHOSISK23MH001905 · NIMH · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI PERKINS, DIANA O. · 2000 to 2004
$826k
6 · The paper itself

Abstract

The prodrome of psychosis has become a target for early identification and for treatments that address both symptoms and risk for future psychosis. Interest and activity in this realm is now worldwide. Clinical trials with rigorous methodology have only just begun, making treatment guidelines premature. Despite the sparse evidence base, treatments are currently applied to patients in the new prodromal clinics, usually treatments developed for established psychosis and modified for the prodromal phase. This communication will describe representative samplings of how treatment-seeking prodromal patients are currently recruited and treated in prodromal clinics worldwide. Recruitment includes how prodromal patients are sought, initially evaluated, apprised of their high-risk status, and informed of the risks and benefits of prodromal treatments and how their mental state is monitored over time. The treatment modalities offered (and described) include engagement, supportive therapy, case management, stress management, cognitive behavioral treatment, family-based treatment, antipsychotic pharmacotherapy, and non-antipsychotic pharmacotherapy. References for details are noted.

Indexed as

Patient Acceptance of Health CarePatient SelectionSchizophrenic PsychologyCase ManagementClinical Trials as TopicCombined Modality TherapyCross-Cultural ComparisonEarly DiagnosisHumansInformed ConsentOutcome and Process Assessment, Health CareRisk ManagementSchizophreniaSchizotypal Personality Disorder

Identifiers

PMID17483100
PMCPMC2526155
OpenAlexW2164388617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.